CRESCENT BIOPHARMA, INC. - CBIO

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$285.9M
QoQ value delta ($000)
+$151.6M (+112.9%)
Implied price effect (QoQ)
-0.3%
Shares
Total shares
24,116,354
QoQ shares delta
+12,822,412 (+113.53%)
Total shares held by funds (by quarter)

Market chart (CBIO)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
FMR LLC 49,023 4,133,514 0.0%
BVF INC/IL 32,600 2,748,763 1.1%
Fairmount Funds Management LLC 32,589 2,747,866 2.48%
VR Adviser, LLC 25,304 2,133,576 1.25%
FCPM III SERVICES B.V. 19,899 1,677,852 2.61%
Vestal Point Capital, LP 17,790 1,500,000 0.6%
Opaleye Management Inc. 13,974 1,178,300 1.84%
TANG CAPITAL MANAGEMENT LLC 10,346 872,398 0.51%
ADAR1 Capital Management, LLC 7,187 606,000 0.53%
Logos Global Management LP 7,116 600,000 0.43%
VANGUARD GROUP INC 6,612 557,506 0.0%
Deep Track Capital, LP 5,380 453,686 0.1%
PERCEPTIVE ADVISORS LLC 5,380 453,686 0.1%
Boxer Capital Management, LLC 5,380 453,686 1.18%
RTW INVESTMENTS, LP 4,422 372,856 0.04%
NEXTBio Capital Management LP 4,422 372,856 2.59%
Remedium Capital Partners, LLC 4,284 361,250 2.52%
PRICE T ROWE ASSOCIATES INC /MD/ 4,011 338,125 0.0%
DRIEHAUS CAPITAL MANAGEMENT LLC 3,587 302,457 0.02%
Point72 Asset Management, L.P. 3,558 300,000 0.0%
HEIGHTS CAPITAL MANAGEMENT, INC 3,131 264,000 1.12%
Alyeska Investment Group, L.P. 3,108 264,000 0.01%
WELLINGTON MANAGEMENT GROUP LLP 1,626 143,412 0.0%
TWO SIGMA INVESTMENTS, LP 1,485 125,224 0.0%
BALYASNY ASSET MANAGEMENT L.P. 1,324 111,715 0.0%